• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • Our Team
  • What We Offer
    • Primary Care
    • Commercial
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • EMIS: Long Term Condition (LTC) Management
      • Medicine Management
        • EMIS: Precision Monitoring Template
        • EMIS: DMARDs and High Risk Drugs
        • EMIS: Safe Prescribing of Opioids / Opiates
      • Specialties
        • EMIS: Cancer
        • EMIS Cardiovascular Overview
          • EMIS: Cardiovascular Disease (AF, CHD, HF, Hypertension)
          • EMIS: Cardiovascular Disease (CVD) Prevention
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
          • EMIS: Peripheral Arterial Disease Guide
        • EMIS Diabetes Overview
          • EMIS Diabetes
          • EMIS: Diabetes Technology
        • EMIS: Care for Frail Patients
        • EMIS: Haematology
        • Infection
          • EMIS: Infections Guide
          • EMIS: Blood Borne Virus (BBV)
        • EMIS: Learning Disabilities
        • EMIS: Neurology Guide
        • EMIS: NHS Health Checks
        • EMIS: Paediatric Assessment
        • EMIS Renal Overview
          • Chronic Kidney Disease (CKD) – EMIS
        • Respiratory Overview
          • EMIS Respiratory Resources
          • BeatAsthma+ Guide for EMIS
        • EMIS: Rheumatology
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Quality and Outcomes Framework (QOF) Guidance for 2023/24
        • SystmOne: NHS Health Checks
        • SystmOne: WorkWell Local Enhanced Service
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • SystmOne Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • SystmOne: Antibiotics Prescribing & Optimisation
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • Suspected Cancer
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • SystmOne Heart Failure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes
          • SystmOne: Diabetes Technology
          • SystmOne Diabetic Kidney Disease
        • ENT Infections
        • Geriatrics Overview
          • SystmOne: Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • Infection Overview
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Report Guide for SystmOne
          • Lipids Protocols
          • Lipid Management Templates
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
        • MSK Referral Management
        • Neurology
        • Obesity Resources
        • Ophthalmology
        • Palliative Care
        • SystmOne Renal/Urology Overview
          • Chronic Kidney Disease (CKD)
        • Respiratory Overview
          • Respiratory Resources
          • Respiratory Infections
        • Rheumatology Overview
          • SystmOne: Osteoporosis and Fragility Fractures
          • Bone Health
      • SystmOne: Weight Management
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
        • 6-8 Week Postnatal Check
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination SystmOne
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • Pneumococcal Vaccination
        • Shingles Vaccination
  • FAQs
  • News and Events
    • Demonstrations
    • Events
      • Recordings
    • Articles
    • Conference abstracts
  • Contact us
You are here: Home / Resources / SystmOne Resource Centre / Medicine Management / Safe Prescribing of Opioids / Opiates

Safe Prescribing of Opioids / Opiates

Harm caused by Opioid medication is a major cause for concern. NICE guidance recommends that Opioids are unlikely to be suitable for controlling primary chronic pain. CDRC has developed series of resources that are available to help support harm reduction. 

Patient Identification Reports

Tackling opioid use can feel like an overwhelming issue. The following reports are designed to help divide this work into manageable chunks, starting with the highest risk patients. 

These reports are available in the CDRC Quality > Pain folder:

Searches ? Opioids 1.1 – 1.6 exclude patients on the palliative care register or taking methadone.

Searches ? Opioids 1.1 – 1.7 detect medication on repeat or being issued repeatedly over the past 3 months.

Performance Monitoring Reports

The following searches can be helpful and can be found in the CDRC Performance > Pain folder: 

Searches 1.0x exclude palliative care patients and patient on methadone.  

ReportPatients 
1.01-1.04 Patients with opiates on repeat prescription or regular scripts in the past 3 months 
1.1 Annual trend in opioid prescribing – number of patients who received at least one script in that financial year 
1.2 As for 1.1 but limited to strong opioids 
2.1-2.5 Current opioid prescribing split by deprivation (if IMD searches set for your area) 

Additional performance data can be found at Home | OpenPrescribing in the Opioid section, with these three charts likely to be the most useful: 

NIPP Project Study Guidance

The searches required for this project are available to all units that are a member of the DCS group on SystmOne. If you are not a member of the DCS group, click here for a step-by-step access guide.

CDRC has created several searches to identify and prioritise patients currently taking opioid medication to potentially reduce their opioid dosage or to substitute their opioid medication for a safer alternative. Not all of these searches are applicable to the NHS Insights Prioritisation Programme (NIPP) opioid study.

For the NIPP Project, a member of staff at your SystmOne practice will run and report on the following searches:

  • ? Opioids 1.1 Likely to be on >100mg morphine equivalent
  • ? Opioids 1.21 Likely to be on >80mg morphine equivalent (not >100mg morphine equivalent)
  • ? Opioids 1.6  Any Opioid

These searches are found in the CDRC Quality > Pain folder and are highlighted below:

NIPP Study Criteria:

Patients targeted will include adults (aged 18 or over) registered with a mobile phone number at practices and those regularly taking opioids for more than 90 days and at dose equivalent to ≥ 90 mg equivalent of morphine a day (this varies for each opioid medication) using electronic records. Patients will be excluded if they are coded cancer or palliative care. Eligible patients will be screened and identified by primary care staff in the participating practices.

Please note:

  • The highlighted searches above exclude patients on palliative care, or taking Methadone/Subutex.
  • These searches include opioids on repeat prescription or >=2 scripts in the last 3 months as a proxy for usage over 90d.
  • The opioid drug combination required to meet the >90mg morphine equivalence is very rare, thus CDRC has created searches ? Opioids 1.1 and ? Opioids 1.2/1.21 to reflect the inclusion criteria as closely as possible.

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
contact-cdrc@healthinnovationnenc.org.uk
This website is operated by Health Innovation North East and North Cumbria. Suite A, 2nd Floor, 1 Citygate, Gallowgate, Newcastle upon Tyne NE1 4WH. Registered in England and Wales, Company Registration Number: 08727658
  • Terms of Reference
  • Privacy policy
  • Terms of use
  • Cookie Policy (UK)
  • Accessibility Statement

Copyright © 2026 Clinical Digital Resource Collaborative

Manage Consent
We use cookies to optimise our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}